Current Status and Future Perspective of Onco-Hypertension

Abstract

Background Hypertension and cancer are both increasing with age. Recently, the new concept of “Onco-Hypertension” has been proposed to address the mutual risks posed by hypertension and cancer and to provide comprehensive care for patients with these two conditions in an aging society. Methods In this review, we provide an overview of the current status and future perspective of the “Onco-Hypertension,” including our research fndings. Results Hypertension and cancer share common risk factors and may be interrelated in pathogenesis: Hypertension is involved in the development of certain cancers, and cancer survivors have a higher incidence of hypertension. With recent advances in cancer therapy, the number of cancer survivors has increased. Cancer survivors not only have a higher risk of incident hypertension but also an increased risk of future cardiovascular events, highlighting the growing importance of comprehensive care. Conclusions There exists a diverse array of epidemiological and pathophysiological relationships between hypertension and cancer. It is imperative to move the emerging scientifc feld of “Onco-Hypertension” forward through relentless research efforts.